Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 332

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part II, Item 5
Chunk 332
---
aap:CustomerConcentrationRiskMember

    2025-03-31
    2025-03-31

    0001946563
    
      sxtp:CustomerThreeMember
      us-gaap:AccountsReceivableMember
      us-gaap:CustomerConcentrationRiskMember

    2025-03-31
    2025-03-31

    0001946563
    
      sxtp:SignificantCustomersMember
      us-gaap:AccountsReceivableMember
      us-gaap:CustomerConcentrationRiskMember

    2024-12-31
    2024-12-31

    0001946563
    
      sxtp:SignificantCustomerOneMember
      us-gaap:SalesRevenueNetMember
      us-gaap:CustomerConcentrationRiskMember

    2025-01-01
    2025-03-31

    0001946563
    
      sxtp:SignificantCustomersMember
      us-gaap:SalesRevenueNetMember
      us-gaap:CustomerConcentrationRiskMember

    2024-01-01
    2024-03-31

    0001946563

    2024-08-12
    2024-08-12

    0001946563
    
      sxtp:NetLossPerCommonShareMember

    2025-02-24
    2025-02-24

    0001946563
    
      us-gaap:FairValueInputsLevel1Member
      us-gaap:DerivativeMember

    2025-03-31

    0001946563
    
      us-gaap:FairValueInputsLevel2Member
      us-gaap:DerivativeMember

    2025-03-31

    0001946563
    
      us-gaap:FairValueInputsLevel3Member
      us-gaap:DerivativeMember

    2025-03-31

    0001946563
    
      us-gaap:DerivativeMember

    2025-03-31

    0001946563
    
      us-gaap:FairValueInputsLevel1Member

    2025-03-31

    0001946563
    
      us-gaap:FairValueInputsLevel2Member